Metastases | Range of metastases size (mm) | 18F-FDG | 68Ga-FAPI | P | |||||
---|---|---|---|---|---|---|---|---|---|
Patient | Location | No. | SUVmax | TBR | SUVmax | TBR | SUVmax | TBR | |
1 | LN | 3 | 7–8 | 5.27 ± 1.29 | 4.39 ± 1.07 | 2.27 ± 0.91 | 2.06 ± 0.82 | ||
2 | LN | 2 | 7–20 | 6.55 ± 0.92 | 7.28 ± 1.02 | 7.10 ± 0.42 | 5.92 ± 0.35 | ||
3 | LN | 2 | 10–16 | 8.10 ± 1.84 | 9.00 ± 2.04 | 14.40 ± 0.85 | 20.57 ± 1.21 | ||
4 | LN | 16 | 7–22 | 10.78 ± 3.13 | 11.98 ± 3.48 | 13.69 ± 4.19 | 22.81 ± 6.98 | ||
Bone | 1 | N/A | 8.00 | 8.89 | 18.20 | 30.33 | |||
5 | LN | 8 | 4–8 | 2.70 ± 1.07 | 3.38 ± 1.33 | 9.41 ± 2.40 | 11.77 ± 3.00 | ||
Bone | 1 | N/A | 8.60 | 10.75 | 20.20 | 25.25 | |||
6 | LN | 2 | 17–22 | 5.60 ± 4.24 | 8.00 ± 6.06 | 5.35 ± 0.92 | 5.94 ± 1.02 | ||
7 | LN | 1 | 17 | 7.60 | 8.44 | 12.80 | 14.22 | ||
8 | LN | 1 | 38 | 25.60 | 36.57 | 15.20 | 19.00 | ||
9 | LN | 4 | 7–17 | 15.78 ± 1.61 | 13.15 ± 1.34 | 3.83 ± 1.32 | 4.25 ± 1.47 | ||
10 | LN | 1 | 27 | 7.30 | 9.13 | 3.10 | 2.58 | ||
11 | LN | 2 | 13–20 | 15.35 ± 3.61 | 19.19 ± 4.51 | 5.60 ± 2.69 | 8.00 ± 3.84 | ||
12 | LN | 3 | 13–21 | 10.80 ± 5.17 | 18.00 ± 8.62 | 5.63 ± 3.82 | 8.05 ± 5.46 | ||
13 | LN | 1 | 10 | 6.20 | 8.86 | 8.60 | 9.56 | ||
14 | LN | 8 | 5–11 | 6.81 ± 4.30 | 11.35 ± 7.17 | 7.60 ± 3.31 | 8.44 ± 3.68 | ||
15 | LN | 1 | 5 | 2.10 | 2.63 | 2.90 | 3.63 | ||
16 | LN | 3 | 12–26 | 12.63 ± 2.29 | 14.04 ± 2.55 | 11.87 ± 3.27 | 14.83 ± 4.08 | ||
Bone | 15 | N/A | 8.08 ± 3.19 | 8.98 ± 3.55 | 5.33 ± 3.86 | 6.66 ± 4.83 | |||
17 | LN | 3 | 10–19 | 8.80 ± 1.28 | 8.00 ± 1.16 | 7.60 ± 0.50 | 15.20 ± 1.00 | ||
18 | LN | 4 | 4–18 | 11.08 ± 9.02 | 11.08 ± 9.02 | 7.58 ± 3.51 | 9.47 ± 4.39 | ||
Sum | LN | 65 | 4–26 | 9.05 ± 5.29 | 10.65 ± 6.59 | 9.08 ± 4.69 | 12.80 ± 8.11 | 0.975 | 0.100 |
Bone | 17 | N/A | 8.11 ± 3.00 | 9.08 ± 3.35 | 6.96 ± 5.87 | 9.14 ± 8.40 | 0.478 | 0.976 |
PET semiquantitative parameters were presented as means with SD.
TBR = tumor-to-background ratio; LN = lymph node; N/A = not applicable.